Below are the most recent publications written about "Hepatitis C" by people in Profiles.
-
Tully DC, Bean DJ, Sarette J, Ngo TL, Power KA, Brook D, Cooper H, Feinberg J, Friedmann PD, Hochstatter KR, Havens JR, Babalonis S, Hurt C, Jenkins W, Korthuis PT, Miller W, Pho MT, Smith G, Stopka TJ, Tsui JI, Mixson LS, Westergaard RP, Young AM, Allen TM. Genomic surveillance uncovers regional variation in HCV transmission networks in rural United States. Nat Commun. 2025 Dec 02; 17(1):249.
-
Min EA, Bolduc P. Prevention and Management of Viral Hepatitis in Primary Care. Top Antivir Med. 2025 Dec; 33(6):711-726.
-
Heinrich F, Wong TLE, Graf W, Dost K, Brennecke A, Kowalski V, van R?th V, Iwersen-Bergmann S, Hajek A, K?nig HH, Renn? T, Brehm TT, Pfefferle S, Schulze Zur Wiesch J, Dandri M, Aepfelbacher M, P?schel K, Ondruschka B, L?tgehetmann M, Stallbaum F. Prevalence and risk factors of viral hepatitis and HIV among people experiencing homelessness in Germany based on a nationwide study. Sci Rep. 2025 Sep 17; 15(1):32571.
-
Farrell CM, Pino EC. Hepatitis C Testing Protocols Across Massachusetts Jails, 2022-2023: An Opportunity for Intervention. Public Health Rep. 2025 Jul-Aug; 140(4):358-364.
-
Mixson LS, Zule W, Ruderman SA, Feinberg J, Stopka TJ, Sibley AL, Walters SM, Bobashev G, Cook R, Hochstatter KR, Fahey CA, Ouellet LJ, Fredericksen R, Cooper HLF, Young AM, Zibbell J, Khoury D, Friedmann PD, Miller WC, Korthuis PT, Westergaard RP, Whitney BM, Tsui JI, Crane HM, Delaney J. Prevalence and correlates of multiple injections per injection episode among people who inject drugs in rural U.S. communities. Int J Drug Policy. 2025 Sep; 143:104837.
-
Estadt AT, Kline D, Miller WC, Feinberg J, Hurt CB, Mixson LS, Friedmann PD, Lowe K, Tsui JI, Young AM, Cooper H, Korthuis PT, Pho MT, Jenkins W, Westergaard RP, Go VF, Brook D, Smith G, Rice DR, Lancaster KE. Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities. Harm Reduct J. 2024 Nov 29; 21(1):214.
-
Stopka TJ, Whitney BM, de Gijsel D, Brook DL, Friedmann PD, Taylor LE, Feinberg J, Young AM, Evon DM, Herink M, Westergaard R, Koepke R, Havens JR, Zule WA, Delaney JA, Pho MT. Medicaid Policy and Hepatitis C Treatment Among Rural People Who Use Drugs. Med Care. 2025 Feb 01; 63(2):77-88.
-
Bennett FJ, Keilson JM, Turgeon MK, Oppat KM, Warren EAK, Shah SA, Agopian VG, Magliocca JF, Cameron A, Orloff SL, Kubal CA, Cannon RM, Akoad ME, Emamaullee J, Aucejo F, Vagefi PA, Nguyen MH, Dhanireddy K, Kazimi MM, Sonnenday CJ, Foley DP, Abdouljoud M, Sudan DL, Humar A, Doyle MBM, Chapman WC, Maithel SK. Racial Disparities in Liver Transplant for Hepatitis C-Associated Hepatocellular Carcinoma. Ann Surg Oncol. 2025 Jan; 32(1):426-437.
-
Bianchet E, de Gijsel D, Del Toro-Mejias LM, Stopka TJ, Hoskinson RA, Dowd P, Friedmann PD. More than Just Buying a Van: Lessons Learned from a Mobile Telehealth HCV Testing and Treatment Study. Viruses. 2024 08 30; 16(9).
-
Romo E, Bianchet E, Dowd P, Mazor KM, Stopka TJ, Friedmann PD. Syringe Access, Syringe Sharing, and Perceptions of HCV: A Qualitative Study Exploring the HCV Risk Environment in Rural Northern New England, United States. Viruses. 2024 08 27; 16(9).